Applies to alirocumab: subcutaneous solution
In addition to its needed effects, some unwanted effects may be caused by alirocumab. In the event that any of these side effects do occur, they may require medical attention.
You should check with your doctor immediately if any of these side effects occur when taking alirocumab:
Some of the side effects that can occur with alirocumab may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:


Applies to alirocumab: subcutaneous solution
The most common adverse reactions leading to treatment discontinuation were allergic reactions and elevated liver enzymes.[Ref]
Very common (10% or more): Hypersensitivity reaction, nummular eczema, hypersensitivity vasculitis[Ref]
Very common (10% or more): Nasopharyngitis (11.3%)Common (1% to 10%): Influenza, bronchitis, sinusitis, cough[Ref]
Common (1% to 10%): Diarrhea[Ref]
Common (1% to 10%): Urinary tract infection[Ref]
Common (1% to 10%): Elevated liver enzyme[Ref]
Common (1% to 10%): Development of antidrug antibody (ADA), neutralizing antibodies (NAb)[Ref]
Patients who developed ADA (antidrug antibody) had a higher incidence of injection site reactions compared with patients who did not develop ADA (10.2% vs 5.9%).[Ref]
Common (1% to 10%): Injection site reaction (erythema, redness, itching, swelling, pain, tenderness)[Ref]
Common (1% to 10%): Myalgia, muscle spasm, contusion, musculoskeletal pain[Ref]
Uncommon (0.1% to 1%): Neurocognitive events, confusion or memory impairment[Ref]
1. "Product Information. Praluent Pen (alirocumab)." sanofi-aventis, Bridgewater, NJ. 
Not all side effects for alirocumab may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Difficulty with breathing or swallowing
fever
hives
nausea
reddening of the skin, especially around the ears
swelling of the eyes, face, or inside of the nose
unusual tiredness or weakness


Cough producing mucus
tightness in the chest


Chills
cough
diarrhea
general feeling of discomfort or illness
headache
joint pain
loss of appetite
muscle aches and pains
redness, itching, swelling, pain at the injection site
shivering
sore throat
stuffy or runny nose
sweating
trouble sleeping
vomiting


Bladder pain
bloody or cloudy urine
difficult, burning, or painful urination
difficulty with moving
frequent urge to urinate
lower back or side pain
muscle pains or stiffness
muscle spasms
pain or tenderness around the eyes and cheekbones
swollen joints

